213 related articles for article (PubMed ID: 36235577)
21. Withania somnifera: From prevention to treatment of cancer.
Palliyaguru DL; Singh SV; Kensler TW
Mol Nutr Food Res; 2016 Jun; 60(6):1342-53. PubMed ID: 26718910
[TBL] [Abstract][Full Text] [Related]
22. Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats.
Khan MA; Subramaneyaan M; Arora VK; Banerjee BD; Ahmed RS
J Complement Integr Med; 2015 Jun; 12(2):117-25. PubMed ID: 25803089
[TBL] [Abstract][Full Text] [Related]
23. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
24. Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.
Saggam A; Tillu G; Dixit S; Chavan-Gautam P; Borse S; Joshi K; Patwardhan B
J Ethnopharmacol; 2020 Jun; 255():112759. PubMed ID: 32173425
[TBL] [Abstract][Full Text] [Related]
25. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
26. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of thermal induced protein denaturation of extract/fractions of Withania somnifera and isolated withanolides.
Khan MA; Khan H; Rauf A; Ben Hadda T
Nat Prod Res; 2015; 29(24):2318-21. PubMed ID: 25649220
[TBL] [Abstract][Full Text] [Related]
28. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
29. [Withania somnifera: a kind of food-medicine plant popular in world in recent years].
Wang Y; Yang KL; He CN; Xiao PG
Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5159-5165. PubMed ID: 34738415
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study.
M M; Zameer F; Naidu A; M N NP; Dhananjaya BL; Hegdekatte R
Pharm Biol; 2016 Sep; 54(9):1936-41. PubMed ID: 26704448
[TBL] [Abstract][Full Text] [Related]
31. Withanolides from Withania somnifera Ameliorate Neutrophil Infiltration in Endotoxin-Induced Peritonitis by Regulating Oxidative Stress and Inflammatory Cytokines.
Balkrishna A; Solleti SK; Singh H; Sharma N; Varshney A
Planta Med; 2022 May; 88(6):466-478. PubMed ID: 33862643
[TBL] [Abstract][Full Text] [Related]
32. Effects of
Della Porta M; Maier JA; Cazzola R
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140274
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
34. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic Study of Withanosides and Withanolides from
Modi SJ; Tiwari A; Ghule C; Pawar S; Saste G; Jagtap S; Singh R; Deshmukh A; Girme A; Hingorani L
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268576
[No Abstract] [Full Text] [Related]
36. Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts.
Kaul SC; Ishida Y; Tamura K; Wada T; Iitsuka T; Garg S; Kim M; Gao R; Nakai S; Okamoto Y; Terao K; Wadhwa R
PLoS One; 2016; 11(12):e0166945. PubMed ID: 27936030
[TBL] [Abstract][Full Text] [Related]
37. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
38. A validated HPTLC method for the simultaneous quantifications of three phenolic acids and three withanolides from Withania somnifera plants and its herbal products.
Tomar V; Beuerle T; Sircar D
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():154-160. PubMed ID: 31200247
[TBL] [Abstract][Full Text] [Related]
39. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
[TBL] [Abstract][Full Text] [Related]
40. Integrated System Pharmacology and
Hannan MA; Dash R; Haque MN; Choi SM; Moon IS
CNS Neurol Disord Drug Targets; 2020; 19(7):541-556. PubMed ID: 32748763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
